BB Biotech AG with net profit after tax of CHF 354 mn for the first half of 2012
(Thomson Reuters ONE) -
BB BIOTECH AG /
BB Biotech AG with net profit after tax of CHF 354 mn for the first half of 2012
. Processed and transmitted by Thomson Reuters ONE.
The issuer is solely responsible for the content of this announcement.
Due to the significant increase in net profit versus last year, BB Biotech AG is
pre-announcing its after-tax result for the first half of 2012 in compliance
with ad hoc publicity rules.
Based on the unaudited consolidated results, after-tax profit for the first half
of 2012 amounts to CHF 354 mn. This result is a reflection of the successful
investment strategy of BB Biotech AG and its consistent implementation.
BB Biotech AG will publish its detailed half-year results on July 19, 2012.
For further information:
Bellevue Asset Management AG, Seestrasse 16, 8700 Küsnacht, Switzerland
Thomas Egger, telephone +41 44 267 67 09, teg(at)bellevue.ch
www.bbbiotech.com
Company profile
BB Biotech invests in companies in the fast growing market of biotechnology and
is one of the world's largest investors in this sector with around CHF 1.2 bn in
assets under management. BB Biotech is listed in Switzerland, Germany and Italy.
Its investments are focused on listed companies that are developing and
commercializing novel medical treatments and cures. BB Biotech's investment
selection process is guided by the fundamental research and analysis of
physicians and molecular biologists. Its Board of Directors has many years of
experience in industry and science.
BB Biotech Press Release (PDF):
http://hugin.info/130285/R/1626461/520392.pdf
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: BB BIOTECH AG via Thomson Reuters ONE
[HUG#1626461]
Datum: 13.07.2012 - 07:01 Uhr
Sprache: Deutsch
News-ID 165011
Anzahl Zeichen: 2389
contact information:
Town:
Schaffhausen
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 272 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"BB Biotech AG with net profit after tax of CHF 354 mn for the first half of 2012"
steht unter der journalistisch-redaktionellen Verantwortung von
BB BIOTECH AG (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
